X0306 4 2018-06-27 false 0001100412 ARRAY BIOPHARMA INC ARRY 0001590157 Robbins Andrew R C/O ARRAY BIOPHARMA INC. 3200 WALNUT ST BOULDER CO 80301 false true false false COO Common Stock 2018-06-27 4 M false 32068.00 0.00 A 191535.00 D Common Stock 2018-06-27 4 F false 14104.00 18.50 D 177431.00 D Common Stock 2018-06-27 4 S false 17964.00 17.74 D 159467.00 D Restricted Stock Units 0.00 2018-06-27 4 M false 32068.00 0.00 D 2018-08-18 Common Stock 32068.00 0.00 D Represents shares released on vesting of Restricted Stock Units ("RSUs") granted to the reporting person on August 18, 2014. The grant of these RSUs was previously reported on Table II. Represents shares withheld to satisfy tax withholding obligations of the reporting person. These trades were made pursuant to a Rule 10b5-1 trading plan. The price reported for these shares is the weighted average sale price of transactions made at prices from $17.60 to $17.84. Details of actual prices for shares sold are available from the Issuer upon request. RSUs representing 32,068 shares of common stock vested upon the achievement of a second milestone relating to the return of rights to binimetinib to the Issuer on or prior to the fourth anniversary of the grant date, subject to continued service with the Issuer as of the vesting date. Jason Haddock, attorney-in-fact for Andrew R. Robbins 2018-06-29